CapsoVision, Inc Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CapsoVision, Inc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 181.15K shares, a 31.82% decline year-over-year.
- CapsoVision, Inc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 106.73K shares, a 21.91% increase year-over-year.
- CapsoVision, Inc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 48.83K shares, a 5417.29% increase year-over-year.
- CapsoVision, Inc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 36.76K shares, a 1.51% increase year-over-year.
- CapsoVision, Inc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 438.81K shares, a 72.82% increase from fiscal 2024.
- CapsoVision, Inc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 253.91K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 181.15K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 373.46K shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 106.73K shares 10-Q · filed 2026-05-14 | 457.99K shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | 48.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 438.81K shares 10-K · filed 2026-03-26 |
| 2025-09-30 | 36.76K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 390.87K shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | 265.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 390.32K shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 87.55K shares 10-Q · filed 2026-05-14 | |
| 2024-12-31 | 885.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 253.91K shares 10-K · filed 2026-03-26 |
| 2024-09-30 | 36.21K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |